Salem Investment Counselors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
WA
AFG
GIC
EAM
IHL
AP
FMI
Salem Investment Counselors's IBB Position: Q2 2026 in Review
Salem Investment Counselors held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 2,126 shares worth $404K. The position accounts for 0.01% of the portfolio, ranked #320.
Salem Investment Counselors first reported a position in IBB in Q3 2016 and has held it in 24 quarters since. 391 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Salem Investment Counselors held 2,126 shares of iShares Biotechnology ETF worth $404K as of Q2 2026.
- Salem Investment Counselors left its iShares Biotechnology ETF share count unchanged in Q2 2026.
- iShares Biotechnology ETF made up 0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #320 holding.
- Salem Investment Counselors first reported a position in iShares Biotechnology ETF in Q3 2016 and has held it in 24 quarters since.
- 391 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.